The Centers for Medicare & Medicaid Services will continue to exercise discretion in enforcing compliance with the payer-to-payer data exchange provisions of its 2020 final rule on interoperability and patient access until it finalizes future rulemaking to address implementation challenges, the agency announced today. 

“We anticipate providing an update on any evaluation of this enforcement discretion notification and related actions during calendar year 2022,” the CMS notice states. 

Effective Jan. 1, 2022, the rule’s payer-to-payer data exchange provisions required Medicare Advantage organizations, Medicaid managed care plans, Children’s Health Insurance Program managed care entities, and qualified health plan issuers on the federally facilitated exchanges to exchange data with other payers at the patient’s request. 
 

Related News Articles

Headline
The Food and Drug Administration May 9 released final guidance clarifying the definition of “remanufacturing” for reusable medical devices needing…
Headline
The Federal Trade Commission April 23 voted 3-2 to issue a final rule that would ban as an unfair method of competition contractual terms that prohibit workers…
Blog
A recent Modern Healthcare article misleadingly suggests that hospitals and health systems provided less charity care between 2020 and 2023. The truth is much…
Headline
On Oct. 31 at 1 p.m. ET, the Food and Drug Administration will host a webinar to review its recent proposed rule for laboratory developed tests,…
Perspective
All hospitals and health systems provide an oasis of care, compassion and healing to the patients and communities they serve. They offer a range of services…
Headline
The Food and Drug Administration the week of July 24 updated its recognized consensus standards database for medical devices to advance innovation in medical…